We have been investigating the molecular and neural mechanisms that control the temporal pattern of egg-laying in C. elegans. In order to observe egg-laying over long periods of time, we used an automated tracking system to record egg-laying events and then analyzed the data to measure intervals between events. These studies have allowed us to construct a model for egg-laying in which the animals fluctuate between two behavioral states: an active state, during which eggs are laid in clusters, and an inactive state , during which eggs accumulate in the uterus. Switching between states, as well as egg-laying within the active state, all model as independent Poisson processes whose rate constants determine the rate of egg-laying. By analyzing the egg-laying patterns of mutants and ablated animals, we have identified neurons and neurotransmitters involved in determining the rate constants. Several lines of evidence indicate that serotonin controls the switch from the inactive to the active state. For example, analyses of the egg-laying pattern of
bas-1 and
cat-4 mutants, both defective in serotonin synthesis, show an increase in the length of the inactive state, but do not affect egg-laying within clusters. Ablation studies have shown that serotonin may be released mainly from the HSNs but possibly also the VC4/5 motor neurons. Intriguingly, ablation of both HSNs and VCs results in a severe Egl phenotype that can not be rescued by serotonin. This indicates that another neurotransmitter, that can be provided by either the HSNs or VCs, is necessary for egg-laying. One possibility is acetylcholine; in fact, addition of both serotonin and the nicotinic agonist, levamisole, to double ablated animals rescues egg-laying, while neither serotonin nor levamisole alone is sufficient. Furthermore, mutants defective in choline acetyltransferase show a decrease in egg-laying within the active phase but have normal intervals between active phases. By studying the egg-laying patterns of Egl mutants, we have begun to characterize signaling pathways that control these two parameters. Some mutants show patterns similar to
cat-4 and HSN-: longer inactive phases but normal egg-laying in clusters. One example is
tpa-1, which is mutant for PKC. Since also serotonin resistant, it might be involved in signaling downstream of serotonin. Other mutants show a different pattern- an absence of clustered egg-laying events, which indicates an involvement in maintaining the active phase. One example is
egl-19, which is mutant for a voltage gated Ca+2 channel. Furthermore,
egl-19 mutants are resistant to serotonin, suggesting them as a target of serotonin in the vulval muscles. One model supporting this data suggests that serotonin is acting to stimulate egg-laying through a PKC dependent phosphorylation of Ca+2 channels, which could potentiate the induction of contraction by acetylcholine.